Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David Cherney
Observed names:
D Cherney,
D Z Cherney,
D. Cherney,
DAVID CHERNEY,
David I Cherney
Institutions:
University Health Network,
University of Toronto,
Toronto General Hospital,
Toronto General Hospital Research Institute
Observed institutions:
Mount Sinai Hospital,
University Health Network,
University of Toronto,
Toronto General Hospital,
Toronto General Hospital Research Institute
OpenAlex ID:
A5109706331
Distinct Oral Neutrophil Subsets Define Health and Periodontal Disease States
2016
·
N. Fine
, S. Hassanpour
, et al.
·
Journal of Dental Research
·
180
Management of patients with hypertensive urgencies and emergencies: A systematic review of the literature
2002
·
David Cherney
, Sharon Straus
·
Journal of General Internal Medicine
·
165
Cystatin C and acute changes in glomerular filtration rate
2012
·
Ayodele Odutayo
, David Cherney
·
Clinical Nephrology
·
58
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials
2024
·
Hiddo J.L. Heerspink
, David Cherney
, et al.
·
Journal of the American Society of Nephrology
·
41
Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
2018
·
KENGO KIDOKORO
, YUJI SOGAWA
, et al.
·
Diabetes
·
34
Effect of Uric Acid-Lowering Agents on Cardiovascular Outcome in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies
2020
·
Mehmet Kanbay
, Baris Afsar
, et al.
·
Angiology
·
30
Remodel: A Mechanistic Trial Evaluating the Effects of Semaglutide on the Kidneys In People With Type 2 Diabetes and Chronic Kidney Disease
2022
·
Petter Bjornstad
, David Cherney
, et al.
·
Nephrology Dialysis Transplantation
·
27
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia
2024
·
Mikhail N. Kosiborod
, David Cherney
, et al.
·
JACC Heart Failure
·
26
Glucagon‐like peptide ‐1 receptor agonists and sodium‐glucose cotransporter ‐2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients
2024
·
Katina Zheng
, Amirhossein Azhie
, et al.
·
Diabetes Obesity and Metabolism
·
19
Biomarkers of Inflammation, Fibrosis, and Acute Kidney Injury in Patients with Heart Failure with and without Left Ventricular Assist Device Implantation
2019
·
Liza Grosman-Rimon
, Sarah Genevieve Hui
, et al.
·
Cardiorenal Medicine
·
9
4b.01: Contrasting Influences of Renal Function on Blood Pressure and Hba1c Reductions With Empagliflozin in Patients With Type 2 Diabetes and Hypertension
2015
·
D. Cherney
, M. Cooper
, et al.
·
Journal of Hypertension
·
8
Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse
2023
·
Stéphan Troyanov
, Arenn Jauhal
, et al.
·
Kidney International Reports
·
7
PDF
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis
2022
·
Arenn Jauhal
, Heather N Reich
, et al.
·
Nephrology Dialysis Transplantation
·
6
PDF
The Effect of SGLT2 Inhibition on Urinary Adenosine Excretion in Patients with Type 1 Diabetes
2016
·
Harindra Rajasekeran
, Yuliya Lytvyn
, et al.
·
Canadian Journal of Diabetes
·
5
791-P: Ertugliflozin in Older Patients with Type 2 Diabetes (T2D): An Analysis from VERTIS CV
2021
·
RICHARD E. PRATLEY
, SAMUEL DAGOGO-JACK
, et al.
·
Diabetes
·
4
Mo051effects of Semaglutide on Chronic Kidney Disease Outcomes: a Post Hoc Pooled Analysis From the Sustain 6 and Pioneer 6 Trials
2020
·
Katherine Tuttle
, David Cherney
, et al.
·
Nephrology Dialysis Transplantation
·
4
Finerenone and Canagliflozin in the Treatment of Chronic Kidney Disease and Type 2 Diabetes: Matching-Adjusted Indirect Treatment Comparison of Fidelio-DKD and Credence
2022
·
David Cherney
, Kerstin Folkerts
, et al.
·
Nephrology Dialysis Transplantation
·
3
To002reduction in the Rate of Egfr Decline With Semaglutide Vs Placebo: a Post Hoc Pooled Analysis of Sustain 6 and Pioneer 6
2020
·
Katherine Tuttle
, David Cherney
, et al.
·
Nephrology Dialysis Transplantation
·
3
Hypernatremia
2000
·
M L Halperin
, D Z Cherney
·
New England Journal of Medicine
·
3
Tirzepatide Reduces Albuminuria in Patients with T2D: Post-hoc Pooled Analysis of SURPASS 1-5
2024
·
Hiddo L Heerspink
, Katherine R Tuttle
, et al.
·
Diabetologie und Stoffwechsel
·
2
Design and Baseline Characteristics of the FIND-CKD Trial: Efficacy of Finerenone on Kidney Disease Progression in People with Non-Diabetic CKD
2023
·
Hiddo J. Heerspink
, Rajiv Agarwal
, et al.
·
Journal of the American Society of Nephrology
·
2
Change in KDIGO Kidney Risk Category With Semaglutide Treatment—A Post Hoc Analysis of the Sustain 6 Trial
2022
·
Katherine Tuttle
, Stephen C Bain
, et al.
·
Nephrology Dialysis Transplantation
·
2
1197-P: Two-Year Effects of Ertugliflozin on Renal Function
2019
·
DAVID CHERNEY
, HIDDO L. HEERSPINK
, et al.
·
Diabetes
·
2
Pharmacotherapeutic Strategies to Prevent Progression to ESKD and Reduce Cardiovascular Risk
2024
·
Ayodele Odutayo
, David Cherney
·
Nephrology Self-Assessment Program
·
1
PDF
Muscle Sympathetic Excitatory Responses to Dynamic One-leg Cycling Exercise Are Augmented in Heart Failure With Preserved Ejection Fraction
2023
·
M. Badrov
, T. Tobushi
, et al.
·
Canadian Journal of Diabetes
·
1
Show more works
View as search
Works count:
83
Citation count:
654
H-index:
9
I10-index:
9
Year
Topic
Type